Journal to publish Sanford clinical diabetes trial
Hunter Arnold, 12, who lives on a farm near Hazel, S.D., and has type 1 diabetes, shows a tube of glucose gel, which he uses if his blood suger gets too low, on Tuesday, July 1, 2014, at the Sanford Children’s Hospital in Sioux Falls, S.D. Arnold, who makes the trip to Sioux Falls to visit the Children’s Hospital every three months to get his insulin pump adjusted, was diagnosed with type 1 diabetes when he was 15-months-old. (Photo: Joe Ahlquist / Argus Leader)
Study tested whether two drugs taken daily could reduce need for insulin shots
An international medical journal is publishing results today of a clinical trial by Sanford Health showing a potential step forward in the Sioux Falls network’s effort to cure Type 1 diabetes.
This morning’s edition of Lancet Diabetes and Endocrinology marks the biggest milestone so far in Sanford’s diabetes project since its corporate makeover seven years ago set the stage for the research.
Failure to protect patient safety and maintain documentation were among the most common violations US regulators cited in warning letters regarding the conduct of clinical trials, according to new data.